FANCM


Summary: The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group M. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

Gene Categories:

DNA REPAIR

GO terms in FANCM


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
MF IEA GO:0003677 DNA binding
MF IDA GO:0003682 chromatin binding
MF IEA GO:0004386 helicase activity
MF IEA GO:0004518 nuclease activity
MF IPI GO:0005515 protein binding
MF IEA GO:0005524 ATP binding
Showing 1 to 6 of 14 rows rows per page

Gene expression in normal tissue: FANCM

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in FANCM


Loading, please wait...
Database
Pathway ID
Pathway Des.
kegg hsa03460 Fanconi anemia pathway - Homo sapiens (human)
pid fanconi_pathway Fanconi anemia pathway
reactome R-HSA-6783310 Fanconi Anemia Pathway
reactome R-HSA-73894 DNA Repair
Showing 1 to 4 of 4 rows

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD255 SB225002 2
iGMDRD801 2,4-dideoxy-DC-45-A2 3
iGMDRD188 Piperlongumine 3
iGMDRD398 Sepantronium 3
Showing 1 to 4 of 41 rows rows per page

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in FANCM

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​